Latest Morning Briefing Stories

How Scientists Decide When A Vaccine’s Risks Outweigh The Number Of People It Will Help

KHN Morning Briefing

While the debate is theoretical, scientists can weigh possible risks versus the lives they know the vaccine will save. But a recent example of a controversial drug is throwing the issue into the global spotlight in a very real way. In other public health news: clinical trials and ethics; decoding a baby’s DNA; home health care workers and infection rates; a new type of self-harm in teenagers; and more.

It Can Be ‘Next To Impossible’ To Find Nursing Facilities That Will Accept Patients Recovering From Opioid Addiction

KHN Morning Briefing

Legal experts say that nursing facilities rejecting patients on addiction medication violates the Americans with Disabilities Act, yet an investigation finds that it’s a common practice. In more news on the crisis: medical groups are advocating for a new reimbursement model of physicians who treat opioid patients; researchers find that organ transplants from overdose victims fare as well as from traditional donors; West Virginia reaches a settlement with a pharmacy over its distributing practices; and more.

A Vaccine For Opioid Addiction? It Might Not Be That Far Off

KHN Morning Briefing

The vaccine would stop opioids by effectively blocking them from reaching the brain by way of the circulatory system. It is one suggestion in a renewed push to treat addiction like a disease rather than a lack of willpower or character flaw.

Cities Feeling Financial Squeeze Of Naloxone As They Try To Rein In High Overdose Rates

KHN Morning Briefing

“Every week, we count the doses we have left and make hard decisions about who will receive the medication and who will have to go without,” said Baltimore Health Commissioner Dr. Leana Wen. In other news on the crisis: more Americans are seeing the epidemic as a significant issue; lawmakers want to pass legislation to curb crisis soon; a look at the effects of stopping long-term use; and more.